Recently, Perez‐Shibayama et al. [25] suggested that the BMP4–gremlin axis represents a potential therapeutic target for modulating myocardial inflammation, thereby reducing the risk of severe complications such as cardiac fibrosis and heart failure. This evidence concerns the gene BMP4 and heart failure.